María D.
Odero
Investigadora hasta 2024
Hospital Virgen del Camino
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Virgen del Camino (6)
2020
-
A new regulatory mechanism of protein phosphatase 2A activity via SET in acute myeloid leukemia
Blood Cancer Journal, Vol. 10, Núm. 1
-
A novel FTY720 analogue targets SET-PP2A interaction and inhibits growth of acute myeloid leukemia cells without inducing cardiac toxicity
Cancer Letters, Vol. 468, pp. 1-13
2007
-
A novel t(2;3)(p11;q27) in a case of follicular lymphoma
Cancer Genetics and Cytogenetics, Vol. 172, Núm. 1, pp. 70-73
2005
-
NUP98 is fused to HOXA9 in a variant complex t(7;11;13;17) in a patient with AML-M2
Cancer Genetics and Cytogenetics, Vol. 157, Núm. 2, pp. 151-156
2003
-
NUP98 is fused to Adducin 3 in a patient with T-cell acute lymphoblastic leukemia and myeloid markers, with a new translocation t(10;11)(q25;p15)
Cancer Research, Vol. 63, Núm. 12, pp. 3079-3083
2002
-
Genomic imbalances detected by comparative genomic hybridization are prognostic markers in invasive ductal breast carcinomas
Histopathology, Vol. 40, Núm. 6, pp. 547-555